Why I Still Prefer the AcrySof IQ
There is a lot for my patients and me to like.
The last few years have brought tremendous innovations to the IOL technology available to ophthalmologists. Advances include small power steps in torics, aspheric presbyopiacorrecting multifocals, IOLs that filter specific wavelengths of light, and most recently, sophisticated aspheric IOLs that counter the naturally occurring positive spherical aberration of the anterior cornea. Of the new-technology aspheric IOLs, I prefer the AcrySof IQ lens (Alcon Laboratories, Inc., Fort Worth, Texas) (Figure 1) for several reasons.
THE REASONS FOR MY PREFERENCE
The AcrySof IQ lens comes on the familiar platform of the AcrySof Natural lens (Alcon Laboratories, Inc.). Surgeons used to implanting the singlepiece acrylic IOL face no learning curve when transitioning to aspheric technology. With a similar edge design and the same high-index acrylic material as the original AcrySof IOLs, the AcrySof IQ lens has a remarkably low rate of posterior capsular opacification. Additionally, the slow and controlled unfolding of this lens during its implantation makes it ideal for eyes with small compromises in the capsular bag such as a limited central defect. In addition, the optic of the AcrySof IQ lens is very thin, noticeably so when compared with other aspheric IOLs.
It is more than 6% thinner than the regular AcrySof single-piece and Natural platforms, which makes it possible to implant the AcrySof IQ lens through incisions smaller than 2.5 mm. I routinely insert this lens through a 2.2-mm incision utilizing the latest Monarch III D cartridge (Alcon Laboratories, Inc.). As advances in phaco technology allow surgeons to use smaller and smaller corneal incisions, it will not be necessary to change to a different IOL. Another beneficial feature of the AcrySof IQ lens is its yellow chromophore. Some compelling studies have shown that filtering the short, energetic wavelengths of light may have possible beneficial effects in preventing choroidal melanoma1 as well as preventing formations in the retinal pigment epithelium associated with age-related macular degeneration.2 The optic of the AcrySof IQ lens is aspheric. With traditional, spherical IOLs, image quality degrades toward the optic’s periphery, because the marginal rays are brought into focus in front of the central rays. The human cornea shares this property, known as positive spherical aberration. In the pseudophakic state, the combination of a traditional spherical IOL and the naturally occurring positive spherical aberration of the cornea increases the total amount of spherical aberration. With a spherical IOL, as the size of the pupil increases, a reduction in contrast sensitivity occurs. An aspheric IOL does not add positive spherical aberration to the optical system.
The most advanced feature of the aspheric optic of the AcrySof IQ lens is that it provides 0.20 μm of negative spherical aberration. With larger pupils, this correction enhances image quality by counteracting the remaining positive spherical aberration of the cornea. Understanding the corrective strategy behind the AcrySof IQ lens helps to explain why the addition of 0.20 μm of negative spherical aberration is an excellent choice for most cataract surgery patients.
COMPENSATORY STRATEGY: THE YOUTHFUL EYE
The AcrySof IQ lens is designed to function much like the youthful crystalline lens by counteracting the naturally occurring positive spherical aberration of the anterior cornea such that the final amount of residual positive spherical aberration approximates that of the youthful eye. The negative spherical aberration of the youthful crystalline lens is typically less than the positive spherical aberration of the anterior cornea. Studies have shown that this negative value commonly ranges between -0.138 and -0.24 μm for young eyes.3-5
Beiko6 found that the positive spherical aberration of the human cornea follows a normal distribution, with an approximate mean value of +0.274 μm. Other studies have shown a similar value, and this amount appears to change very little with age7,8 (Figures 2 and 3). If the mean positive spherical aberration value of the cornea is +0.275 μm and the negative spherical aberration value of the young crystalline lens is somewhere between -0.138 and -0.24 μm, then the net result is a small amount of naturally occurring positive spherical aberration. It is interesting that this value is often symmetrical.9
On the optical bench, image quality would normally be the best if all higher-order aberrations were corrected down to zero. Intuitively, one would expect that correcting all spherical aberration for the human eye would also produce the best visual performance. The clinical literature suggests otherwise. A small amount of positive spherical aberration may be the optimal choice for human vision.5,6,10-14
A comprehensive clinical study by Beiko15 compared the visual performance of two groups of matched patients with the Tecnis lens (Advanced Medical Optics, Inc., Santa Ana, California): one with zero mean residual spherical aberration of the whole eye for a 6-mm pupil and another with positive 0.1 μm of residual spherical aberration for the same pupillary size. Beiko found that targeting a residual positive spherical aberration of 0.1 μm following cataract surgery resulted in superior visual performance.
He also demonstrated that eyes implanted with the Acrysof IQ lens that have an average of 0.1 μm of positive residual spherical aberration achieved higher contrast sensitivity when compared to eyes implanted with the Tecnis lens that had no residual positive spherical aberration. Similarly, Legras et al10 found that, for a 6-mm pupil, the optimal value for spherical aberration was not zero but 0.08 μm. These findings are the reason that the targeted value of spherical aberration for the AcrySof IQ lens, in particular, for the average pseudophakic eye is approximately +0.1 μm (+0.075 μm).
At present, three aspheric IOLs are available in North America. For a 6-mm pupil, the Tecnis lens models 0.275 μm of negative spherical aberration, the AcrySof IQ lens adds 0.20 μm of negative spherical aberration, and the SofPort AO IOL (Bausch & Lomb, Rochester, New York) adds none. I use a 6-mm pupillary size, because it is an accepted industry standard for the design considerations with aspheric optics and ocular aberrometry methods for diagnostic purposes. In an ideal world, surgeons would measure the amount of anterior corneal spherical aberration for each patient prior to cataract surgery and match this value to an IOL with the optimal correction for this higher-order aberration. In the real world, the expense of using such technology currently makes such an exercise impractical.
What I like about the AcrySof IQ lens is that the smallest number of patients will be over- or undercorrected with 0.20 μm of negative spherical aberration added to their pseudophakic optical system. With the SofPort AO lens, almost every patient will be undercorrected, whereas somewhat less than half will be overcorrected with the Tecnis.
It is helpful to remember that, in the presence of small pupils, the AcrySof IQ, Tecnis, SofPort AO, and any spherical IOL all perform about the same in terms of contrast sensitivity. With small pupils, moreover, I doubt that anyone could tell a difference. With pupils of 4 mm or larger, however, the correction of anterior corneal spherical aberration begins to make a difference in both image quality and visual performance, as shown by contrast sensitivity testing.16-18 Again, the ideal would be to match the IOL with the measured anterior corneal spherical aberration (this is different than the whole-eye wavefront) of the individual patient for a 6-mm pupil and to leave approximately 0.1 μm of residual positive spherical aberration. As part of the IOL power calculation process in my office, we now measure the anterior corneal spherical aberration of each patient prior to cataract surgery. For those surgeons seeking to fully optimize outcomes, all you really need to know is whether or not the 6-mm anterior corneal Z(4,0) value is low, medium, or high. You may then select the best corresponding IOL. The SofPort AO lens and the SN60AT lens (Alcon Laboratories, Inc.) would work best with low values, the AcrySof IQ IOL would be an optimal choice with medium values, and the Tecnis lens gives good results for high values. For the majority of my patients, however, the AcrySof IQ lens ends up being the most suitable.
With each year, the line that separates cataract from refractive surgery fades further. Many of my patients who have received the AcrySof IQ lens tell me their uncorrected vision is the best that it has been since they were teenagers. The goal of aspheric IOLs with negative spherical aberration is the approximation of a Z(4,0) value of the youthful eye. Such comments from patients confirm that lens technology is on the right track. ■
1. Marshall JC, Gordon KD, McCauley CS, et al. The effect of blue light exposure and use of intraocular lenses on human uveal melanoma cell lines. Melanoma Res. 2006;16:537-541.
2. Rezai KA, Gasnya E, et al. AcrySof Natural filter decreases blue light-induced apoptosis in human retinal pigment epithelium. Graefe's Arch Clin Exp Ophthalmol. 2008;246:671-676.
3. Wang L, Santaella RM, Booth M, Koch DD. Higher order aberrations from the internal optics of the eye. J Cataract Refract Surg. 2005;31:1512-1519.
4. Hong X. Optical Aberrations of Human Eye and Their Impact on Visual Performance [dissertation]. Bloomington, IN: Indiana University; 2001.
5. He JC, Gwiazda J, Thorn, F, Held R. Wavefront aberrations in the anterior corneal surface and the whole eye. J Opt Soc Am A Opt Image Sci Vis. 2003;20:1155-1163.
6. Beiko G. Personalized correction of spherical aberration in cataract surgery. Paper presented at: The AAO Annual Meeting; October 18, 2005; Chicago, IL.
7. Wang L, Dai E, Koch DD. Optical aberrations of the human cornea. J Cataract Refract Surg. 2003;29:1514-1521.
8. Amano S, Amano Y, Yamagami S, et al. Age-related changes in corneal and ocular higher order wavefront aberrations. Am J Ophthalmol. 2004;137:988-992.
9. Wang L, Koch DD. Ocular higher-order aberrations in individuals screened for refractive surgery. J Cataract Refract Surg. 2003;29:1896-1903.
10. Legras R, Chateau N, Charman WN. Assessment of just-noticeable differences for refractive errors and spherical aberration using visual stimulation. Optom Vis Science. 2004;81:718-728.
11. Levy Y, Segal O, Avni I, Zadok D. Ocular higher order aberrations in eyes with supranormal vision. Am J Ophthalmol. 2005;139:225-228.
12. Amesbury EC, Schallhorn SC. Contrast sensitivity and limits of vision. Int Ophthalmol Clin. 2005;43:31-42.Ω
13. Altmann GE, Nichamin SS, Lane SS, Pepose JS. Optical performance of 3 intraocular lens designs in the presence of decentration. J Cataract Refract Surg. 2005;31:574-585.
14. Thibos LN, Hong X. Bradley A, Cheng X. Statistical variation of aberration structure and image quality in a normal population of healthy eyes. J Opt Soc Am A Opt Image Sci Vis. 2002;19:2329-2348.
15. Beiko G. Personalized correction of spherical aberration in cataract surgery. J Cataract Refract Surg. 2007;33:1455-1460.
16. Awwad ST, Warmerdam D, Bowman RW, et al. Contrast sensitivity and higher order aberrations in eyes implanted with AcrySof IQ SN60WF and AcrySof SN60AT intraocular lenses. J Refract Surg. 2008;24:619-625.
17. Tzelikis PF, Akaishi L, Trindade FC, Boteon JE. Ocular aberrations and contrast sensitivity after cataract surgery with AcrySof IQ intraocular lens implantation Clinical comparative study. J Cataract Refract Surg. 2007;33:1918-1924.
18. Pandita D, Raj SM, Vasavada VA, et al. Contrast sensitivity and glare disability after implantation of AcrySof IQ Natural aspherical intraocular lens: prospective randomized masked clinical trial. J Cataract Refract Surg. 2007;33:603-610.
TOP 5 ARTICLES FROM 2009
- My Standpoint on Monovision as a Cataract Surgeon
The success of monovision depends on the level of targeted myopia for near vision.
By Graham D. Barrett, MD, FRACO
- Outcomes of Refractive Lens Exchange: A Review of Cases
Complication rates were low, and visual outcomes were good in a large series.
By Karl G. Stonecipher, MD
- Sutureless Intrascleral Posterior Chamber IOL Fixation
This technique is less technically demanding than transscleral suturing or gluing and enables the surgeon to easily recenter the lens.
By Gabor B. Scharioth, MD; and Diego de Ortueta, MD, FEBO
- Special Considerations in Combined Cataract Surgery, DSAEK
In combination with cataract removal, special care is needed for DSAEK, but the procedure does convey advantages.
By W. Barry Lee, MD, FACS
- Challenges in IOL Surgery
A panel of surgeons presents rationales for treatment choices in thought-provoking cases.
By Jorge L. Alió, MD, PhD; Roberto Bellucci, MD; Francesco Carones, MD; Charles Claoué, MA(Cantab), MD, DO, FRCS, FRCOphth, FEBO, MAE; Jose L. Güell, MD; Oliver K. Klaproth, Dipl Ing(FH); Thomas Kohnen, MD; Frederico F. Marques, MD, PhD; Daniela M.V. Marques, MD, PhD; Erik L. Mertens, MD, FEBOphth; Tobias H. Neuhann, MD; Mark Packer, MD, FACS; Magda Rau, MD; Marie-José Tassignon, MD, PhD, FEBO; William B. Trattler, MD; Abhay R. Vasavada, MS, FRCS; and Robert J. Weinstock, MD